| Literature DB >> 26490383 |
Alexei Kharitonenkov1, Richard DiMarchi2.
Abstract
The biology of fibroblast growth factor 21 (FGF21) has evolved through its first decade at a revolutionary pace with dramatic refinements in this relatively short span of time. This field is poised now with a deeper understanding of its specific physiological role, pathological ramifications for its inappropriate function, and a much-enriched context of the complex hormonal network in which it serves to regulate metabolism. As a derivative of these discoveries, the application of FGF21 as a medicinal agent has emerged with structurally optimized protein-based analogs being preclinically explored in multiple species, and, more recently, through clinical studies. These novel findings set a foundation for ongoing inquiries that structure future research into this intriguing protein. Published by Elsevier Ltd.Entities:
Keywords: FGF21; FGFR; KLB; drug development; hormones; metabolic regulation
Mesh:
Substances:
Year: 2015 PMID: 26490383 DOI: 10.1016/j.tem.2015.09.007
Source DB: PubMed Journal: Trends Endocrinol Metab ISSN: 1043-2760 Impact factor: 12.015